Heart Disease News and Research

Latest Heart Disease News and Research

Global Strategy for Women's and Children's Health draws more than $40 billion in resources

Culminating a global summit on the Millennium Development Goals (MDGs), United Nations Secretary-General Ban Ki-moon and Heads of State and Government, along with the private sector, foundations, international organizations, civil society and research organizations, kicked off a concerted world-wide effort to save the lives of more than 16 million women and children.

23 Sep 2010

Physicians' health habits could affect their abilities to counsel patients on diet, exercise

Physician's confidence in their abilities to counsel patients on a healthy diet and exercise may be related to their own personal habits, according to a study by the University of Michigan Cardiovascular Center.

23 Sep 2010

Athersys presents MultiStem phase I study results at TCT Conference

Athersys, Inc. announced at its presentation at the Transvascular Cardiovascular Therapeutics (TCT) Conference held in Washington, D.C., updated results from its phase I clinical trial of MultiStem, its allogeneic cell therapy product, administered to individuals following acute myocardial infarction (AMI).

23 Sep 2010

SynCardia temporary Total Artificial Heart wins 2010 Kerrin Rennie Award

On Sept. 15, the SynCardia temporary Total Artificial Heart was awarded the 2010 Kerrin Rennie Award for Excellence in Medical Technology by the Medical Technology Association of Australia (MTAA).

23 Sep 2010

Abbott announces positive results of bioresorbable vascular device at TCT conference

Abbott today announced positive nine-month results from the first 45 patients enrolled in the second stage of the ABSORB trial. At nine months, Abbott's bioresorbable vascular scaffold (BVS) demonstrated strong results that remained consistent with the six-month data from the same 45-patient group, with the rate of major adverse cardiac events (MACE) unchanged at 4.4 percent and no reports of blood clots (thromboses).

23 Sep 2010

Gersak develops Convergent Procedure for atrial fibrillation

During the recent Atrial Fibrillation Session of the Techno College at the European Association of Cardiac Thoracic Surgeons in Geneva, Switzerland, Professor Borut Gersak, Head of Cardiac Surgery from University Medical Center in Ljubljana, Slovenia challenged his audience of more than 1,000 medical professionals to think differently about existing atrial fibrillation surgical approaches.

23 Sep 2010

NextGen Healthcare becomes CCHIT Certified for Dermatology and Behavioral Health

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare information systems and connectivity solutions, today announced that NextGen® Ambulatory EHR version 5.6, a CCHIT Certified® 2011 Ambulatory EHR, has been additionally certified for Dermatology and Behavioral Health in the Certification Commission for Health Information Technology's (CCHIT®) certification program.

23 Sep 2010

Erasmus Medical Center Professor to present LEADERS trial result at TCT symposium

Three-year data from the prospective, randomized LEADERS trial demonstrate the equivalence of a biolimus A9-eluting stent with a biodegradable polymer vs. a sirolimus-eluting stent with a durable polymer. The results will be presented at the 22nd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation.

23 Sep 2010

Study finds adverse cardiac events rare during year after negative cardiac CTA scan

Adverse cardiac events are rare one year after patients are admitted to the emergency room with low-to-moderate risk chest pain and are discharged due to a negative cardiac computed tomography angiogram (CTA), according to a study in the October issue of the American Journal of Roentgenology. Cardiac CTA is a noninvasive heart-imaging test that determines whether fatty deposits or calcium deposits have built up in the coronary arteries that supply blood to the heart muscle.

23 Sep 2010

St. Jude Medical to highlight OCT product platform at TCT meeting

St. Jude Medical, Inc., a global medical device company, will highlight recently launched technology, including its new Optical Coherence Tomography (OCT) product platform, at the 22nd annual Transcatheter Cardiovascular Therapeutics (TCT) meeting in Washington, D.C.

23 Sep 2010

Resistance training program can help maintain metabolic health: Research

Although obesity is a major risk factor for disease, much of the threat may be associated with the metabolic (or cardiometabolic) syndrome, a cluster of risk factors related to diabetes and heart disease. Losing weight can improve health and reduce many of these risk factors. However, many people struggle to keep the weight off long-term.

23 Sep 2010

TAVI procedure effective in patients unsuitable for surgical valve replacement: Study

One-year data from the PARTNER clinical trial, published today in the New England Journal of Medicine, demonstrate that transcatheter aortic-valve implantation, compared with standard therapy, resulted in significantly lower rates of death among patients who cannot undergo surgery for aortic stenosis. The results will be presented tomorrow as a Late Breaking Trial at the 22nd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.

23 Sep 2010

New study signals hope for treatment of rare neurodegenerative disease

A new study led by St. Jude Children's Research Hospital scientists signals hope for treatment of a neurodegenerative disease and a new model for understanding the mechanism at work in other more common neurodegenerative disorders.

23 Sep 2010

MAQUET enrolls first patient in OPTION trial

MAQUET Cardiovascular LLC, a leading provider of cardiovascular technologies, today announced enrollment of the first patient in the OPTION (Optimal Improvement of Vein Graft Patency Long Term by the Implementation Of Novel Endoscopic Harvesting Techniques) trial which is designed to assess patient outcomes using a standardized, best practices approach in endoscopic vessel harvesting (EVH) for coronary artery bypass graft surgery (CABG) compared with open vein harvesting methods.

23 Sep 2010

New study calls future parents to understand effects of perinatal events on child development

Approximately 5,000 families (pregnant women, fathers and newborns) are being asked to take part in a new study called Étude 3-D (Découvrir, Développer, Devenir) that is aimed at understanding the effects of perinatal events on child development. The study is directed by Dr. William Fraser, Associate Director of Clinical Research at the CHU Sainte-Justine and professor of Medicine at the University of Montreal.

23 Sep 2010

Novartis applauds declaration of CML Awareness Day in Canada

Today is a meaningful milestone for chronic myelogenous leukemia (CML) patients and their families.

23 Sep 2010

Implantation of new bioprosthetic-tissue valve in patients with severe aortic stenosis saves lives

Implantation of a new bioprosthetic-tissue valve into the hearts of patients who have severe aortic stenosis and are too sick or too old for open-heart surgery has been found to both save lives and improve the quality of those lives, according to a new multicenter study, to be published online at 2 p.m. Pacific time today in the New England Journal of Medicine.

23 Sep 2010

Chromium picolinate may cure inflammation associated with diabetic nephropathy: Research

Taking chromium picolinate may help lessen inflammation associated with diabetic nephropathy (kidney disease), say researchers at the Medical College of Georgia in Augusta.

23 Sep 2010

Revolutionary technology 'cooks' brain tumor

University Hospitals (UH) Case Medical Center is offering new hope for patients with inoperable brain tumors or lesions previously diagnosed as untreatable through a revolutionary technology called AutoLITT which "cooks" brain tumors with an MRI-guided laser. UH becomes one of only three medical centers in the world offering AutoLITT as part of its arsenal in the fight against cancer. It is especially effective in treating glioblastoma, one of the most aggressive and difficult-to-treat brain cancers.

23 Sep 2010

First intestine transplant in Michigan performed on 50-year-old Port Austin patient

The first intestine (bowel) transplant in Michigan was performed on a 50-year-old patient from Port Austin by physicians at Henry Ford Hospital.

23 Sep 2010

Heart Disease News and Research

Latest Heart Disease News and Research

Global Strategy for Women's and Children's Health draws more than $40 billion in resources

Physicians' health habits could affect their abilities to counsel patients on diet, exercise

Athersys presents MultiStem phase I study results at TCT Conference

SynCardia temporary Total Artificial Heart wins 2010 Kerrin Rennie Award

Abbott announces positive results of bioresorbable vascular device at TCT conference

Gersak develops Convergent Procedure for atrial fibrillation

NextGen Healthcare becomes CCHIT Certified for Dermatology and Behavioral Health

Erasmus Medical Center Professor to present LEADERS trial result at TCT symposium

Study finds adverse cardiac events rare during year after negative cardiac CTA scan

St. Jude Medical to highlight OCT product platform at TCT meeting

Resistance training program can help maintain metabolic health: Research

TAVI procedure effective in patients unsuitable for surgical valve replacement: Study

New study signals hope for treatment of rare neurodegenerative disease

MAQUET enrolls first patient in OPTION trial

New study calls future parents to understand effects of perinatal events on child development

Novartis applauds declaration of CML Awareness Day in Canada

Implantation of new bioprosthetic-tissue valve in patients with severe aortic stenosis saves lives

Chromium picolinate may cure inflammation associated with diabetic nephropathy: Research

Revolutionary technology 'cooks' brain tumor

First intestine transplant in Michigan performed on 50-year-old Port Austin patient

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Heart Disease News and Research

Latest Heart Disease News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in